The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Danilov D.S.

Klinika psikhiatrii im. S.S. Korsakova;
kafedra psikhiatrii i meditsinskoĭ psikhologii Moskovskoĭ meditsinskoĭ akademii im. I.M. Sechenova

A 70-year history of tricyclic antidepressants

Authors:

Danilov D.S.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2019;119(12): 115‑123

DOI: 10.17116/jnevro2019119121115

Read: 27964 times

Download PDF (RU)
Contact the author
Table of contents

A 70-YEAR HISTORY OF TRICYCLIC ANTIDEPRESSANTS
A 70-YEAR HISTORY OF TRICYCLIC ANTIDEPRESSANTS

To cite this article:

Danilov DS. A 70-year history of tricyclic antidepressants. S.S. Korsakov Journal of Neurology and Psychiatry. 2019;119(12):115‑123. (In Russ.)
https://doi.org/10.17116/jnevro2019119121115

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова (S.S. Korsakov Journal of Neurology and Psychiatry)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
The state of mental health of migrant workers and citi­zens of the Russian Fede­ration: A comparative analysis as illu­strated by the Moscow region. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4):95-101
Factors of depression acco­rding to acti­graphy in the fall season. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5-2):27-32
Identification of depression biomarkers: Prospects for use in clinical practice. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5):51-55
Depression Anxiety Stress Scale (russian language version). S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5):103-107
Inve­stigation of the rela­tionship of indi­vidual characteristics of the brain bioelectrical acti­vity with levels of mental stress, aggression, anxiety, and depression. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5):108-117
Modern concepts of sleep disturbances asso­ciated with mental diso­rders. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(6):7-12
Vali­dation of the Snaith—Hamilton Pleasure Scale to assess anhe­donia in patients with unipolar depression In Russia. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(7):110-121
Factors supporting chro­nic inflammation in mental illness. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(8):7-15
Gender characteristics of cardiovascular diseases psychosocial risk factors asso­ciations with sleep quality in an open urban popu­lation. Russian Journal of Preventive Medi­cine. 2025;(6):67-73
Dysfunctional pelvic pain in women. Russian Journal of Pain. 2025;(2):32-37
Abstract:

For the first time the facts from the history of tricyclic antidepressants (TCA) are systematized in Russian psychiatric literature. The authors describe the history of first TCA agents, analyze the history of TCA group development based on the increase of new agents, present the history of original TCA creation in the USSR and the Eastern block countries, systemize the history of TCA classification development and review the studies on TCA neurochemical activity. An impact of TCA history on formulation of hypotheses of the pathogenesis of depression and some forms of neuroses is demonstrated. It is shown that the history of TCA creation urged the development of new groups of antidepressants.

Keywords:

tricyclic antidepressants
imipramine
amitriptyline
clomipramine
desipramine
trimipramine
chloracyzine
fluacizine (phroracizine)
pipofezine
dosulepin (dothiepine)
prazepine (propazepine)
classification of tricyclic antidepressants
mechanism action of tricyclic antidepressants
noradrenaline
serotonin
depression
neuroses
history of tricyclic antidepressants

Authors:

Danilov D.S.

Klinika psikhiatrii im. S.S. Korsakova;
kafedra psikhiatrii i meditsinskoĭ psikhologii Moskovskoĭ meditsinskoĭ akademii im. I.M. Sechenova

Close metadata

References:

  1. Schindler W, Haefliger F. Über derivate des iminodibenzyls. Helvetica Chimica Acta. 1954;37(2):472-483. https://doi.org/10.1002/hlca.19540370211
  2. Healy D. The Psychopharmacologists. Vol. 3. New York: Oxford University Press; 2000.
  3. Kuhn R. The discovery of the tricyclic antidepressants and the history of their use in early years. In: A history of the CINP. Brentwood, Tn: JM Productions. 1996;425-435.
  4. Brown WA, Rosdolsky M. The clinical discovery of imipramine. American Journal Psychiatry. 2015;172(5):426-429. https://doi.org/10.1176/appi.ajp.2015.14101336
  5. Ban TA. In memory of three pioneers. International Journal Neuropsychopharmacology. 2006;9:475-477. https://doi.org/10.1017/S1461145706006870
  6. Cahn C. Roland Kuhn, 1912—2005. Neuropsychopharmacology. 2006;31:1096. https://doi.org/10.1038/sj.npp.1301026
  7. Bekker RA, Bykov YuV, Morozov PV. Pol’ Kil’khol’ts i ego vklad v mirovuyu psikhiatriyu. V kn.: Vydayushchiesya psikhiatry XX v. M.: ID «Gorodets»; 2019. (In Russ.)
  8. Morozov PV. Interv’yu s Zhyulem Angstom. Dnevnik Psikhiatra. 2012;3:1-5. (In Russ.)
  9. Banshchikov VM, Stolyarov GV. Psikhicheskie narusheniya pri lechenii tofranilom. V kn.: Voprosy klinicheskoi psikhiatrii (Trudy 1-go Moskovskogo ordena Lenina meditsinskogo instituta im. I.M. Sechenova). Pod red. Banshchikova V.M. M.: 1-i Moskovskii ordena Lenina meditsinskii institut im. I.M. Sechenova. 1964. (In Russ.)
  10. Nemeroff ChB, Kelsi DzhE. Affektivnye rasstroistva. V kn.: Farmakoterapiya v nevrologii i psikhiatrii. Pod red. Enn S.D., Koil Dzh.T. Per. s angl. M.: MIA; 2007. (In Russ.)
  11. Aleksandrovskii YuA. M.D. Mashkovskii — odin iz sozdatelei otechestvennoi psikhofarmakologii. V kn.: Istoriya otechestvennoi psikhiatrii. T. 3. Psikhiatriya v litsakh. M.: GEOTAR-Media; 2013. (In Russ.)
  12. Rapoport A. Psikhicheskie bolezni. V kn.: Bol’shaya meditsinskaya entsiklopediya. Izd. 2-e. Glav. red. Bakulev A.N. T. 27. M.: Sovetskaya entsiklopediya; 1962. (In Russ.)
  13. Gross H, Kaltenbaeck E. Clinical experiences with the dibenzocycloheptadiene derivative amitriptyline (Ro 4-1575) in psychiatric patients (article in German). Wiener Medizinische Wochenschrift. 1961;111:256-258.
  14. Aleksandrowicz J. Amitryptyline (Elavil, MK-230) — a new antidepressant (article in Polish). Neurologia Neurochirurgia Psychiatria Polska. 1962;12:759-764.
  15. Mashkovskii MD. Lekarstvennye sredstva. Izd. 6. T. 1. M.: Meditsina; 1967. (In Russ.)
  16. Psikhofarmakologiya i lechenie nervnykh i psikhicheskikh zabolevanii. Materialy konferentsii, 9—12 dekabrya 1964 g. Red. Khvilitskii T.Ya., Nuller Yu.L. L.: Gosudarstvennyi nauchno-issledovatel’skii psikhonevrologicheskii institut im. V.M. Bekhtereva; 1964. (In Russ.)
  17. Antidepressanty i lechenie depressivnykh sostoyanii (psikhofarmakologicheskie i klinicheskie issledovaniya). Trudy Leningradskogo nauchno-issledovatel’skogo psikhonevrologicheskogo instituta im. V.M. Bekhtereva. T. XXXIV. Red.: Lapin I.P., Khvilitskii T.Ya.; obshch. red.: Kabanov M.M., Myasishchev V.N. L.: Izdatel’stvo «Meditsina» Leningradskoe otdelenie; 1966. (In Russ.)
  18. Mikhalenko IN, Nuller YuL. Clinical trial of damilen (amitriptylene). Zhurnal Nevropatologii i Psikhiatrii im. S.S. Korsakova. 1967;67(1):131-135. (In Russ.)
  19. Germane SK. Tritsiklicheskoe antidepressivnoe sredstvo damilen-maleinat. Khimiko-Farmatsevticheskii Zhurnal. 1974;9:60-62. (In Russ.)
  20. Insel TR. Obsessive compulsive disorder. Psychiatric Clinics North America. 1985;8:105-117.
  21. Snyder S. Amitriptyline therapy of obsessive compulsive neurosis. Journal Clinical Psychiatry. 1980;41:286-289.
  22. Fernandez CE, Lopez-Ibor JJ. Use of monochlorimipramine in the treatment of psychiatric patients resistant to other therapies (article in Spanish). Actas Luso-Españolas Neurología Psiquiatría. 1967;26(2):119-147.
  23. Healy D. The antidepressant era. Cambridge: Harvard University Press. 1997.
  24. Yaryura-Tobias JA. Obsessive-compulsive disorders: A serotonergic hypothesis. Journal Orthomolecular Psychiatry. 1977;6(4):317-326.
  25. Yaryura-Tobias JA, Berbirian RJ, Neziroglu FA, Bhagavan HN. Obsessive-compulsive disorder as a serotonergic defect. Research Communications Psychology Psychiatry Behaviour. 1977;2:279-286.
  26. Zaidel’ K, Kulavik Kh, Shakhmatov NF, Shakhmatov NF, Bobrova IN. Maniakal’no-depressivnyi psikhoz. V kn.: Rukovodstvo po psikhiatrii. Red. Morozov G.V. V 2-kh t. T. I. M.: Meditsina; 1988. (In Russ.)
  27. Neduva AA. Mesto preparatov gidifen, gerfonal i petilil v sovremennoi timoanalepticheskoi terapii. Sotsial’naya i Klinicheskaya Psikhiatriya. 1995;5(1):107-110. (In Russ.)
  28. Shternberg EYa. Psikhofarmakologiya. V kn.: Bol’shaya meditsinskaya entsiklopediya. Izd. 2-e. Glav. red. Bakulev A.N. T. 27. M.: Sovetskaya entsiklopediya; 1962;377-380. (In Russ.)
  29. Aleksandrovskii YuA, Borinevich VV, Shchirina MG. Sovremenie psichofarmacologicheskie sredstva. V kn.: Voprosy psikhofarmakologii. Trudy Gosudarstvennogo nauchno-issledovatel’skogo instituta psikhiatrii ministerstva zdravookhraneniya RSFSR. T. XXXV. Red. Fedotov D.D. M.: Ministerstvo zdravookhraneniya RSFSR, Gosudarstvennyi nauchno-issledovatel’skii institut psikhiatrii; 1962.377-380. (In Russ.)
  30. Portnov AA, Fedotov DD. Psikhiatriya. 3-e izd. M.: Meditsina; 1971. (In Russ)
  31. Psychotropic agent. Part I: antipsychotics and antidepressants. Ed. Hoffmeister F., Stille G. Berlin—Heidelberg—New York. 1980.
  32. Klinicheskaya psikhiatriya. Per. s angl. Red. Dmitrieva T.B. M.: GEOTAR-Meditsina; 1998. (In Russ.)
  33. Nuller YuL, Mikhalenko IN. Affektivnye psikhozy. L.: Meditsina» 1988. (In Russ.)
  34. Kielholz P. Psyhiatrische pharmakotherapie in klinic und praxis. Bern: Stuttgart; 1965.
  35. Kielholz P, Labhardt F, Battegay R, Rummele W, Feer H. Therapy of depressions and depressive states (article in German). Deutsche Medizinische Wochenschrift. 1963;88(34):1617-1624.
  36. Chiodo LA, Antelman SM. Repeated tricyclics induce a progressive dopamine autoreceptor subsensitivity independent of daily drug treatment. Nature. 1980;287(5781):451-454. https://doi.org/10.1038/287451a0
  37. Bazhin AA, Nuller YuA. Primenenie khloratsizina dlya lecheniya depressivnykh sostoyanii. Zhurnal Nevropatologii i Psikhiatrii im. S.S. Korsakova. 1963;63(10):1546-1548. (In Russ.)
  38. Mashkovskii MD. Lekarstvennye sredstva. Izd. 8. T. 1. M.: Meditsina; 1977. (In Russ.)
  39. Lapin IP. Comparative pharmacological data on the use of chlorazicin and tofranil on psychiatric practice. Zhurnal Nevropatologii i Psikhiatrii im. S.S. Korsakova. 1964;64(2):281-299. (In Russ.)
  40. Burnazyan GA. Psikhofarmakoterapiya. Erevan: Aistan; 1980. (In Russ.)
  41. Kaverina NV. Khloratsizin. V kn.: Bol’shaya meditsinskaya entsiklopediya. Izd. 3-e. Glav. red. Petrovskii B.V. T. 27. M.: Sovetskaya entsiklopediya; 1986. (In Russ.)
  42. Prikaz Minzdrava SSSR ot 15.10.69 №737 «O razreshenii meditsinskogo primeneniya i ob isklyuchenii iz nomenklatury lekarstvennykh sredstv». (In Russ.). https://www.lawmix.ru/med/18843
  43. Mashkovskii MD. Lekarstvennye sredstva. Izd. 7-e. T. 1. M.: Meditsina; 1972. (In Russ.)
  44. Raevskii KS. Ftoratsizin. V kn.: Bol’shaya meditsinskaya entsiklopediya. Izd. 3-e. Glav. red. Petrovskii B.V. T. 26. M.: Sovetskaya entsiklopediya; 1985. (In Russ.)
  45. Prokudin VN. Peculiarities of clinical action antidepressant Azafen in treatment of depressive disorders in somatic patients in general hospital. Psikhiatriya i Psikhofarmakoterapiya. 2011;13(5):22-25. (In Russ.)
  46. Avrutskii GYa, Vovin RYa, Lichko AE, Smulevich AB. Biologicheskaya Terapiya Psikhicheskikh Zabolevanii. L.: Meditsina; 1975. (In Russ.)
  47. Shinaev NN, Akzhigitov RG, Galkina IV, Volkova NP, Rudneva NI. Azafen (pipofezin) — vozvrashchenie v klinicheskuyu praktiku. Russkii Meditsinskii Zhurnal. 2006;23:1722-1724. (In Russ.)
  48. Shinaev NN, Dachevskaya II, Akzhigitov RG. Opyt lecheniya pogranichnykh psikhicheskikh rasstroistv v «Klinike nevrozov». Rossiiskii Psikhiatricheskii Zhurnal. 2000;1:54-58. (In Russ.)
  49. Ivanets NN, Vinnikova MA, Mokhnachev SO, Boiko EO, Gurevich GL, Pinskaya NV. Rezul’taty slepogo platsebo-kontroliruemogo klinicheskogo issledovaniya otechestvennogo preparata Azafen (pipofezin). Psikhiatriya i Psikhofarmakoterapiya. 2007;9(2):33-37. (In Russ.)
  50. Tyuvina NA, Balabanova VV, Prokhorova SV, Kozlov IA. Effektivnost’ Azafena-MV (pipofezina) pri lechenii depressii raznoi stepeni tyazhesti. Psikhiatriya i Psikhofarmakoterapiya. 2008;10(6):41-45. (In Russ.)
  51. Vyas JN, Sharma P, Singhal AK, Agarwal S. A comparative study of dothiepin (prothiaden) and imipramine in depression. Indian Journal Psychiatry. 1989;31(2):151-156.
  52. Vencovsky E, Peterova E. Our preliminary clinical experiences with Prothiadene (article in Czech). Ceskoslovenská Psychiatrie. 1962;58:327-328.
  53. Rydzynski Z. Investigation of antidepressant activity of prothiaden. Neurologia Neurochirurgia Psychiatria Polska. 1966;16:1159-1162.
  54. Theobald W. K voprosu o spektre farmakologicheskogo deistviya tritsiklicheskikh antidepressivnykh sredstv. V kn.: Depressii. Voprosy kliniki, psikhopatologii, terapii. Doklady, predstavlennye na simpoziume, prokhodivshem 10—12 sentyabrya 1970 g. v Moskve. Red. Shternberg E.Ya., Smulevich A.B. Moscow—Bazel’: Upravlenie po vnedreniyu novykh lekarstvennykh sredstv i meditsinskoi tekhniki MZ SSSR, Farmatsevticheskaya firma SIBA-GEIGI, Institut psikhiatrii AMN SSSR; 1970. (In Russ.)
  55. Avrutskii GYa, Gurovich IYa, Gromova VV. Farmakoterapiya psikhicheskikh zabolevanii. M.: Meditsina; 1974. (In Russ.)
  56. Smulevich AB. Maloprogredientnaya shizofreniya i pogranichnye sostoyaniya. M.: Meditsina; 1987. (In Russ.)
  57. Gubskii YuI, Shapovalova VA, Kut’ko II, Shapovalov VV. Lekarstvennye sredstva v psikhofarmakologii. Kiev: Zdorov’ya; Khar’kov: Torsing; 1997. (In Russ.)
  58. Metysova J, Votava Z. Comparison of pharmacological properties of propazepine and imipramine (article in Czech). Activitas Nervosa Superior. 1961;3:227.
  59. Rysánek K, Vítek V, Svehla C. Serotonin level in human and animal thrombocytes after imipramine and propazepine administration. Activitas Nervosa Superior. 1965;7:261-262.
  60. Vojtechovsky M, Safratova V, Soukupova B. The influence of propazepine on learning and memory in healthy volunteers and in patients with slight chronic brain syndrome. Activitas Nervosa Superior. 1970;12(3):251-252.
  61. Nuller YuL. Depressiya i depersonalizatsiya. L.: Meditsina; 1981. (In Russ.)
  62. Sigg EB. Pharmacological studies with tofranil. Canadian Journal Psychiatry. 1959;4(1 suppl):75-85. https://doi.org/10.1177/070674375900401S07
  63. Axelrod J, Whitby LJ, Hertting G. Effect of psychotropic drugs on the uptake of H3-norepinephrine by tissues. Science. 1961;133(3450):383-384. https://doi.org/10.1126/science.133.3450.383
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.